Immediate Impact
38 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
2023 Standout
Works of Guillaume Direz being referenced
Association between hidradenitis suppurativa and spondyloarthritis
2017
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guillaume Direz | 33 | 27 | 36 | 128 | 78 | 7 | 244 | |
| C-T Chou | 33 | 18 | 38 | 81 | 29 | 9 | 285 | |
| D D McGavin | 30 | 10 | 19 | 93 | 145 | 6 | 273 | |
| Peter M. Banks | 8 | 4 | 9 | 99 | 44 | 7 | 298 | |
| Ayşegül Usta | 17 | 16 | 38 | 110 | 225 | 5 | 263 | |
| Aideen Hogan | 7 | 2 | 34 | 88 | 236 | 9 | 291 | |
| Susan M. Malinowski | 9 | 10 | 18 | 66 | 249 | 8 | 276 | |
| Raphaël Depaz | 11 | 37 | 104 | 133 | 11 | 259 | ||
| Guillermo Berbotto | 8 | 1 | 16 | 200 | 32 | 8 | 240 | |
| Y Schoenfeld | 10 | 3 | 16 | 88 | 21 | 7 | 284 | |
| J. V. Forrester | 7 | 3 | 24 | 91 | 172 | 9 | 267 |
All Works
Loading papers...